
DexCom (DXCM) Stock Forecast & Price Target
DexCom (DXCM) Analyst Ratings
Bulls say
DexCom is expected to continue its growth trajectory with its continuous glucose monitoring systems, both in the traditional diabetic patient market and in the expanding consumer biosensor market. With its focus on software and engagement, an impressive product pipeline, and a strong management team, DexCom is poised for continued success in the industry. However, potential risks include increased competition, delays in product releases, and potential pricing pressures.
Bears say
DexCom is facing regulatory risks with potential delays in launching new products and potential pricing pressures from payors. They also face high levels of investment and competition in the diabetes device sector, making profitability challenging. Despite positive data on the benefits of their CGM technology, there may be concerns about sustainability and adoption on a larger scale, indicating a potential risk to their long-term growth and financial success.
This aggregate rating is based on analysts' research of DexCom and is not a guaranteed prediction by Public.com or investment advice.
DexCom (DXCM) Analyst Forecast & Price Prediction
Start investing in DexCom (DXCM)
Order type
Buy in
Order amount
Est. shares
0 shares